CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 279 filers reported holding CONMED CORP in Q1 2022. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178 | -5.8% | 2 | -98.1% | 0.00% | -100.0% |
| Q1 2023 | $189 | -99.9% | 104 | -56.7% | 0.01% | +20.0% |
| Q3 2022 | $146,000 | -16.1% | 240 | -16.7% | 0.01% | 0.0% |
| Q2 2022 | $174,000 | -35.6% | 288 | -35.6% | 0.01% | -37.5% |
| Q1 2022 | $270,000 | +4.7% | 447 | +4.9% | 0.01% | +33.3% |
| Q4 2021 | $258,000 | +96.9% | 426 | +1604.0% | 0.01% | -90.3% |
| Q3 2021 | $131,000 | -4.4% | 25 | +4.2% | 0.06% | +26.5% |
| Q2 2021 | $137,000 | -42.4% | 24 | +1100.0% | 0.05% | +880.0% |
| Q1 2021 | $238,000 | – | 2 | 0.0% | 0.01% | – |
| Q4 2020 | $0 | -100.0% | 2 | 0.0% | 0.00% | – |
| Q1 2020 | $129,000 | +15.2% | 2 | -98.8% | 0.00% | -100.0% |
| Q4 2019 | $112,000 | – | 172 | +3340.0% | 0.08% | – |
| Q2 2018 | $0 | -100.0% | 5 | -99.2% | 0.00% | -100.0% |
| Q1 2018 | $44,000 | – | 666 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
| Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
| Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
| Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
| EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
| Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
| MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
| Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
| EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |